Filing News

COLUMBIA, Md.--(BUSINESS WIRE)--Welldoc®, a leader in AI-powered cardiometabolic health solutions, today announced the submission of a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for its Continuous Glucose Monitor (CGM)-Informed Glucose Prediction Feature. This submission builds on the company's foundation of 11 FDA 510(k) clearances for type 1 and type 2 diabetes capabilities. The software feature predicts glucose values up to 2 hours for individuals with type...

NEW YORK--(BUSINESS WIRE)--World Liberty Financial today announced that WLTC Holdings LLC filed a de novo application to the Office of the Comptroller of the Currency (OCC) to establish World Liberty Trust Company, National Association (WLTC), a proposed national trust bank purpose-built for stablecoin operations. The charter will position WLTC to issue USD1, the dollar-backed stablecoin that has reached over $3.3 billion in circulation in its first year. The trust company plans to serve instit...

DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC) (“Healthpeak”) today announced that it has confidentially submitted a draft registration statement on Form S-11 to the United States Securities and Exchange Commission (“SEC”) relating to the proposed initial public offering (“IPO”) of shares of common stock of a newly formed company, Janus Living, Inc. (“Janus Living”), that intends to elect and qualify to be taxed as a real estate investment trust. Janus Living will own, acquire...

NEW YORK--(BUSINESS WIRE)--Morgan Stanley Investment Management (MSIM) announced today that it has filed initial registration statements with the Securities and Exchange Commission (SEC) for two new exchange-traded products (ETPs). Morgan Stanley Bitcoin Trust and Morgan Stanley Solana Trust are pending regulatory approval and would be passive investment vehicles that seek to track the performance of the price of the relevant cryptocurrency. Registration statements relating to the securities of...

WEST PALM BEACH, Fla. & ZEPHYR COVE, Nev.--(BUSINESS WIRE)--Hennessy Capital Investment Corp. VII (NASDAQ: HVII) (“Hennessy VII”), and ONE Nuclear Energy LLC (“ONE Nuclear”), an independent developer of large-scale energy solutions powered by natural gas and advanced nuclear technologies, today announced that Hennessy VII filed a registration statement on Form S-4 with the U.S. Securities and Exchange Commission (“SEC”) on December 23, 2025, in connection with their previously announced propose...

LAS VEGAS--(BUSINESS WIRE)--ALT5 Sigma Corporation (the “Company” or “ALT5”) (NASDAQ: ALTS)(FRA: 5AR1), a fintech company operating institutional-grade global payments, trading, and settlement infrastructure, today announced that it expects to file its 10-Q for the quarter ended September 27, 2025 in the coming days. The Company's 10-Q filing was delayed, resulting in a compliance notice from Nasdaq regarding late filing requirements. ALT5 has been in ongoing communication with Nasdaq and is ac...

BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has received a notification letter dated January 2, 2026 (the “Notification Letter”) from Nasdaq Listing Qualifications (“Nasdaq”), stating that the Company was not in compliance with Nasdaq’s Listing Rule 5250(c)(2) since the Company did not timely file a Form 6-K containing an interim balance sheet and income statement as...

SUNNYVALE, Calif. & SINGAPORE--(BUSINESS WIRE)--KNOREX Ltd. (NYSE American: KNRX) (“KNOREX” or the “Company”), a leading provider of AI-driven programmatic online advertising products and solutions, today provided a year-end business update highlighting significant commercial progress, including one of the strongest quarters of ad spend transacted through XPO in the Company’s history, as it executes on growth initiatives following its successful NYSE American listing in September. In connection...

IRVINE, Calif.--(BUSINESS WIRE)--SBC announced an updated capital allocation strategy for future growth....

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced the submission of a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) seeking clearance for the use of KORU Medical’s FreedomEDGE® infusion system to subcutaneously a...